Conclusions and recommendations
300. The management of the introduction of the
MMC reforms by the Department of Health was inept. Key policy
decisions and the processes for making and documenting them were
ineffective and the medical profession, while frequently consulted,
rarely influenced critical decisions. The governance systems for
the programme were far too complicated, roles and responsibilities
were ill-defined and lines of accountability were irrational and
blurred. The arbitrary division of responsibilities between the
Chief Medical Officer and the Workforce directorate was a fatal
fault line within the management of the programme.
301. Project management for the introduction of
changes to specialty training was equally poor. Much of the key
planning for the 2007 changes took place in a mad scramble at
the end of 2006. The "big bang" approach to the reforms
and the failure to pilot any of the new arrangements proved particularly
serious errors. Individual risks to the project were assessed,
but problems were not made known to senior officials and there
was no risk management of the project as a whole. As a result,
the Department did not recognise the deficiencies within the programme
and could not prevent implementation from going ahead prematurely.
Project management decisions took little account of the needs
and concerns of applicants themselves and communication with junior
doctors was appalling.
302. The leadership shown by the Department of
Health during this period was totally inadequate. Despite being
the architect of the reforms, the Chief Medical Officer chose
not to take on a clear leadership role and thus did not accept
overall responsibility for the 2007 crisis. The confidence of
the medical profession in the current CMO has been seriously damaged
by MMC. Serious criticisms of the CMO have arisen in part because
of the ambiguity of the role. We recommend that the job description
be reviewed to define the role more accurately and then publicised
to facilitate wider understanding of the CMO's duties and responsibilities.
303. The Department has already made a number
of changes to programme management in light of the 2007 crisis
and in response to the Tooke Inquiry. The governance systems for
MMC have been simplified and improved and a single line of accountability
established. The new MMC Programme Board appears to give the medical
profession a more meaningful role in decision-making. And the
Department has adopted a more conservative approach to implementing
future reforms.
304. We welcome these changes. However, the constitution,
independence and leadership of the MMC Programme Board remain
too vague to provide assurance that it can develop and implement
effective solutions to the challenges identified in this report.
Members of the current Board themselves warned that the views
of the profession are still not receiving adequate attention.
We therefore recommend the following additional improvements to
programme management for MMC by the Department of Health:
- Members of the Programme
Board should be selected in equal numbers by the Department of
Health and bodies representing the medical profession; a similar
process should be used to select Chairs for the Programme Board;
- All future policy development decisions should
be approved by the MMC Programme Board;
- A document reviewing the principles behind
the MMC reforms should be agreed by the Programme Board and published
by August 2008;
- Meetings and decisions of the Programme Board
must be properly minuted and attendance at the Programme Board
should be consistent;
- All future changes should be piloted and evaluated;
- A "big bang" approach to reform
should be avoided wherever possible in future;
- Communication with junior doctors should be
improved and a single source of authoritative information established;
and
- Complete clarity is required regarding the
roles of the CMO and the NHS Medical Director in the delivery
of MMC. The Department should make clear how the CMO's role as
professional lead for doctors in England can be carried out effectively
given his distant relationship with MMC.
305. In particular, these changes should help
to ensure that the new Programme Board represents a genuine partnership
between the Department of Health, the NHS and the medical profession.
Such an approach is vital if the new Board is to avoid the weaknesses
and pitfalls which affected the previous UK Strategy Group and
the Douglas Review group.
306. We also recommend the following improvements,
which the Department should apply to all future change programmes:
- The Department should produce, and publish
where appropriate, formal business cases to support major change
projects. The expected costs and benefits of reforms should be
clearly stated and, if possible, quantified.
- Formal mechanisms for reviewing progress and
risks across the whole of projects should be introduced. Regular
reviews should inform decisions about whether timetables for the
implementation of change are realistic.
- The Permanent Secretary should monitor all
substantial change programmes being conducted by the Department
and should ensure that other senior officials are informed about
the progress of key projects.
- The Department must ensure that project management
is adequately resourced and proper training provided. Managing
major change projects should not be regarded as a task that can
be tacked on to existing job roles.
- Ministers and officials should set more realistic
timescales for introducing major changes, and should be prepared
to delay implementation if necessary.
307. The leaders of the medical profession itself
were also ineffective, divided by factional interests and unable
to speak with a coherent voice. The weak and tokenistic nature
of the Academy of Medical Royal Colleges was exposed by the MMC
crisis. We therefore recommend that the Royal Colleges review
the role of the Academy of Medical Royal Colleges and consider
replacing it with an executive body which has the authority to
make decisions on behalf of all the Colleges.
269